glp-1/gip agonists Frontiers Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic

Efficacy and safety of exenatide once weekly versus liraglutide in subjects with type 2 diabetes (DURATION-6): a randomised, open-label study [abstract 75]

Current recommendations include 150 to 300 minutes of moderate intensity exercise and 2 to 3 sessions of resistance training per week

The FDA also warns not to take Saxenda if you have a personal or family history of multiple endocrine neoplasia syndrome Type 2, medullary thyroid cancer, or insulin-dependent diabetes

Additional mechanistic studies will however be necessary to fully understand the molecular action of tirzepatide

You Can Watch More on OncoDaily Youtube TV